TNF and arthritic joint disease: By using a specific LMP7 inhibitor in vivo, it was possible to suppress arthritis with production of pro-inflammatory cytokines such as TNF-alpha and IL-23 [41], opening new possibilities for the treatment of autoimmune diseases.